-
41
The Patient-Reported Outcomes Thermometer–5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases
Published 2018-01-01“…To investigate the construct validity, reliability (internal consistency and retest reliability), and feasibility of the patient-reported outcomes thermometer–5-item scale (5T-PROs), a new tool to measure overall health status in patients with painful chronic rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axialSpA), and fibromyalgia (FM). …”
Get full text
Article -
42
COVID-19 vaccine hesitancy: A telephonic survey in patients with systemic lupus erythematosusxs
Published 2022-01-01Subjects: “…autoimmune rheumatic diseases…”
Get full text
Article -
43
Integrated analyses uncover new features of atypical memory B cells and novel targets for intervention
Published 2025-03-01Subjects: Get full text
Article -
44
Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
Published 2025-01-01Subjects: Get full text
Article -
45
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
Published 2023-06-01“…Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19 vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational study.Methods Consecutive cases of IRD encountered during a 12-month period and satisfying one of the following inclusion criteria: (a) onset of the rheumatic manifestations within 4 weeks from SARS-CoV-2 infection or (b) onset of the rheumatic manifestations within 4 weeks from the administration of one of the COVID-19 vaccines ws recruited.Results The final analysis cohort comprised 267 patients, of which 122 (45.2%) in the post-COVID-19 and 145 (54.8%) in the postvaccine cohort. …”
Get full text
Article -
46
Systemic lupus erythematosus in a patient with 22q11.2 deletion syndrome: A case report and review of the literature
Published 2024-11-01Subjects: Get full text
Article -
47
-
48
A Rare and Intriguing Case of Wilson's Disease Initially Suspected of Systemic Lupus Erythematosus
Published 2025-01-01Get full text
Article -
49
Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response
Published 2015-06-01“…Knowing the impact of obesity on rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis) is thus an important issue. …”
Get full text
Article -
50
-
51
-
52
-
53
-
54
Clinical utility of anti-cyclic citrullinated peptid and rheumatoid factor in chronic hepatitis B virus infection
Published 2018-01-01“…Background: It is necessary to distinguish whether musculoskeletal symptoms are associated with rheumatic diseases or hepatitis virus infection. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) may be detected in rheumatic diseases and also during infections. …”
Get full text
Article -
55
-
56
Long COVID in patients with rheumatologic disease: A single center observational study
Published 2023-01-01“…Conclusions: The long COVID syndrome is common in patients with and without rheumatic diseases, and the prevalence of each of these symptoms differs little between these groups. …”
Get full text
Article -
57
-
58
-
59
-
60
Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets—A Focus on the JAK-STAT Pathway
Published 2018-01-01“…Chronic pain is nowadays considered not only the mainstay symptom of rheumatic diseases but also “a disease itself.” Pain is a multidimensional phenomenon, and in inflammatory arthritis, it derives from multiple mechanisms, involving both synovitis (release of a great number of cytokines) and peripheral and central pain-processing mechanisms (sensitization). …”
Get full text
Article